MA54866A - Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques - Google Patents

Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques

Info

Publication number
MA54866A
MA54866A MA054866A MA54866A MA54866A MA 54866 A MA54866 A MA 54866A MA 054866 A MA054866 A MA 054866A MA 54866 A MA54866 A MA 54866A MA 54866 A MA54866 A MA 54866A
Authority
MA
Morocco
Prior art keywords
triterpenoid
antifungals
fungal
treatment
osteoarticular infections
Prior art date
Application number
MA054866A
Other languages
English (en)
French (fr)
Inventor
Gonzalez David A Angulo
Original Assignee
Scynexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scynexis Inc filed Critical Scynexis Inc
Publication of MA54866A publication Critical patent/MA54866A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
MA054866A 2019-01-30 2020-01-30 Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques MA54866A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962798743P 2019-01-30 2019-01-30

Publications (1)

Publication Number Publication Date
MA54866A true MA54866A (fr) 2022-05-04

Family

ID=69740705

Family Applications (1)

Application Number Title Priority Date Filing Date
MA054866A MA54866A (fr) 2019-01-30 2020-01-30 Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques

Country Status (7)

Country Link
US (2) US20220117948A1 (cg-RX-API-DMAC7.html)
EP (1) EP3917534B1 (cg-RX-API-DMAC7.html)
JP (1) JP7562542B2 (cg-RX-API-DMAC7.html)
CN (1) CN113498343A (cg-RX-API-DMAC7.html)
EA (1) EA202192107A1 (cg-RX-API-DMAC7.html)
MA (1) MA54866A (cg-RX-API-DMAC7.html)
WO (1) WO2020160316A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020276595B2 (en) * 2019-05-16 2025-12-04 Scynexis, Inc. Antifungal Agents for Candida Auris Decolonization

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
ES2402659T3 (es) 2006-04-03 2013-05-07 Merck Sharp & Dohme Corp. Derivados de enfumafungina como agentes antifúngicos
WO2010019204A1 (en) * 2008-08-12 2010-02-18 Merck Sharp & Dohme Corp. Antifungal agents
BRPI0912074B1 (pt) * 2008-08-12 2021-08-03 Merck Sharp & Dohme Corp Composto e composição farmacêutica
US20210002346A1 (en) * 2016-11-29 2021-01-07 Cidara Therapeutics, Inc Methods for preventing fungal infections

Also Published As

Publication number Publication date
EP3917534B1 (en) 2024-07-03
US20220117948A1 (en) 2022-04-21
EA202192107A1 (ru) 2021-10-21
CN113498343A (zh) 2021-10-12
EP3917534A1 (en) 2021-12-08
WO2020160316A1 (en) 2020-08-06
US20250248983A1 (en) 2025-08-07
JP2022519500A (ja) 2022-03-24
JP7562542B2 (ja) 2024-10-07

Similar Documents

Publication Publication Date Title
MA45539A (fr) Dihydropyranopyrimidines pour le traitement d'infections virales
EP3641829A4 (en) INTERFERON PRODRUG FOR TREATMENT OF CANCER
EP3431105A4 (en) MEDICAL COMPOSITION FOR THE TREATMENT OF CANCER
EP3908270A4 (en) COMBINATION OF DEXTROMETHORPHANE AND BUPROPION FOR THE TREATMENT OF DEPRESSION
MA47719A (fr) Esketamine pour le traitement de la dépression
EP3426258A4 (en) CATIONIC STEROIDAL ANTIBIOTIC COMPOSITIONS FOR THE TREATMENT OF SKIN TISSUE
EP3691639A4 (en) CHROMAN MONOBACTAM COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTION
MA44083A (fr) Composés de biarylmonobactame pour le traitement d'infections bactériennes
EP3946357A4 (en) TOPICAL FORMULATIONS FOR THE TREATMENT OF PERIPHERAL NEUROPATHIES
EP3645040A4 (en) USE OF ANTI-FAM19A5 ANTIBODIES FOR CANCER TREATMENT
MA43825A (fr) Schémas posologiques pour le traitement d'infections fongiques
EP3651801A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF MUSHROOM INFECTION
EP3374350A4 (en) HYDROXYPYRIDINONE- AND HYDROXYPYRIMIDINONE-BASED COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
MA55218A (fr) Eskétamine pour le traitement de la dépression
EP3541417A4 (en) COMBINATION IMMUNOTHERAPIES FOR TREATING CANCER
EP3655404A4 (en) COMPOUNDS AND THEIR USE TO TREAT MICROBIAL INFECTIONS
EP3773221A4 (en) TREATMENT OF HYDROCEPHALUS
EP3541379A4 (en) COMPOSITIONS FOR THE TREATMENT OF HYPERTONIA
EP3766497A4 (en) Drug for treating cough
EP3716966A4 (en) ALPHA-KETO ACID COMPOSITIONS FOR THE TREATMENT OF HYPOALBUMINEMIA
EP3344325A4 (en) LOCAL ADMINISTRATION OF MEDICAMENTS FOR THE TREATMENT OF ASTHMA
MA45334A (fr) Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes
EP3634431A4 (en) THERAPEUTIC COMPOSITIONS AND METHODS OF TREATMENT FOR HEPATITIS B
EP3630080A4 (en) USE OF EZH2 INHIBITORS TO TREAT CANCER
EP3612214A4 (en) ENZYME REPLACEMENT THERAPY OPTIMIZATION FOR THE TREATMENT OF HOMOCYSTINURIA